Screening of substance use in pregnancy: A Danish cross‐sectional study

Abstract Introduction There is a paucity of objectively verified data on substance use among Danish pregnant women. We estimated the prevalence of substance use including alcohol and nicotine among the general population of Danish pregnant women. Material and Methods In this anonymous, national, cro...

Full description

Saved in:
Bibliographic Details
Main Authors: Nete Lundager Klokker Rausgaard, Inge Olga Ibsen, Palle Bach Nielsen Fruekilde, Ellen Aagaard Nohr, Per Damkier, Pernille Ravn
Format: Article
Language:English
Published: Wiley 2024-07-01
Series:Acta Obstetricia et Gynecologica Scandinavica
Subjects:
Online Access:https://doi.org/10.1111/aogs.14862
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849687805067788288
author Nete Lundager Klokker Rausgaard
Inge Olga Ibsen
Palle Bach Nielsen Fruekilde
Ellen Aagaard Nohr
Per Damkier
Pernille Ravn
author_facet Nete Lundager Klokker Rausgaard
Inge Olga Ibsen
Palle Bach Nielsen Fruekilde
Ellen Aagaard Nohr
Per Damkier
Pernille Ravn
author_sort Nete Lundager Klokker Rausgaard
collection DOAJ
description Abstract Introduction There is a paucity of objectively verified data on substance use among Danish pregnant women. We estimated the prevalence of substance use including alcohol and nicotine among the general population of Danish pregnant women. Material and Methods In this anonymous, national, cross‐sectional, descriptive study, pregnant women were invited when attending an ultrasound scan between November 2019 and December 2020 at nine Danish hospitals. Women submitted a urine sample and filled out a questionnaire. Urine samples were screened on‐site with a qualitative urine dipstick for 15 substances including alcohol, nicotine, opioids, amphetamines, cannabis, and benzodiazepines. All screen‐positive urine samples underwent secondary quantitative analyses with gold standard, liquid chromatography‐tandem mass spectrometry (LC–MS/MS) analysis. Results were compared to questionnaire information to analyze the validity of self‐reporting and to examine possible cross‐reactions. Results A total of 1903 of 2154 invited pregnant women participated (88.3%). The prevalence of dipstick‐positive urine samples was 25.0%. 44.0% of these were confirmed positive, resulting in a total confirmed prevalence of 10.8%. The prevalence of nicotine use was 10.1%—and for all other substances, <0.5%. Nicotine use was more prevalent among younger pregnant women, while other substance use appeared evenly distributed over age groups. Self‐reporting of use of nicotine products was high (71.1%), but low for cannabis and alcohol intake (0% and 33.3%, respectively). Prescription medication explained almost all cases of oxycodone, methylphenidate, and benzodiazepine use. Conclusions Substance use among pregnant women consisted mainly of nicotine. Dipstick screening involved risks of false negatives and false positives. Except for alcohol intake and cannabis use, dipstick analyses did not seem to provide further information than self‐reporting. LC–MS/MS analyses remain gold standard, and future role of dipstick screenings should be discussed.
format Article
id doaj-art-4865d3dab8ca4d9a99b87cf3dc8c65fc
institution DOAJ
issn 0001-6349
1600-0412
language English
publishDate 2024-07-01
publisher Wiley
record_format Article
series Acta Obstetricia et Gynecologica Scandinavica
spelling doaj-art-4865d3dab8ca4d9a99b87cf3dc8c65fc2025-08-20T03:22:14ZengWileyActa Obstetricia et Gynecologica Scandinavica0001-63491600-04122024-07-0110371408141910.1111/aogs.14862Screening of substance use in pregnancy: A Danish cross‐sectional studyNete Lundager Klokker Rausgaard0Inge Olga Ibsen1Palle Bach Nielsen Fruekilde2Ellen Aagaard Nohr3Per Damkier4Pernille Ravn5Department of Clinical Research University of Southern Denmark Odense DenmarkDepartment of Gynecology and Obstetrics Odense University Hospital Odense DenmarkDepartment of Clinical Biochemistry Odense University Hospital Odense DenmarkDepartment of Clinical Research University of Southern Denmark Odense DenmarkDepartment of Clinical Research University of Southern Denmark Odense DenmarkDepartment of Clinical Research University of Southern Denmark Odense DenmarkAbstract Introduction There is a paucity of objectively verified data on substance use among Danish pregnant women. We estimated the prevalence of substance use including alcohol and nicotine among the general population of Danish pregnant women. Material and Methods In this anonymous, national, cross‐sectional, descriptive study, pregnant women were invited when attending an ultrasound scan between November 2019 and December 2020 at nine Danish hospitals. Women submitted a urine sample and filled out a questionnaire. Urine samples were screened on‐site with a qualitative urine dipstick for 15 substances including alcohol, nicotine, opioids, amphetamines, cannabis, and benzodiazepines. All screen‐positive urine samples underwent secondary quantitative analyses with gold standard, liquid chromatography‐tandem mass spectrometry (LC–MS/MS) analysis. Results were compared to questionnaire information to analyze the validity of self‐reporting and to examine possible cross‐reactions. Results A total of 1903 of 2154 invited pregnant women participated (88.3%). The prevalence of dipstick‐positive urine samples was 25.0%. 44.0% of these were confirmed positive, resulting in a total confirmed prevalence of 10.8%. The prevalence of nicotine use was 10.1%—and for all other substances, <0.5%. Nicotine use was more prevalent among younger pregnant women, while other substance use appeared evenly distributed over age groups. Self‐reporting of use of nicotine products was high (71.1%), but low for cannabis and alcohol intake (0% and 33.3%, respectively). Prescription medication explained almost all cases of oxycodone, methylphenidate, and benzodiazepine use. Conclusions Substance use among pregnant women consisted mainly of nicotine. Dipstick screening involved risks of false negatives and false positives. Except for alcohol intake and cannabis use, dipstick analyses did not seem to provide further information than self‐reporting. LC–MS/MS analyses remain gold standard, and future role of dipstick screenings should be discussed.https://doi.org/10.1111/aogs.14862alcoholcannabishigh risk pregnancymaternal–fetal medicinematernity careneonatology
spellingShingle Nete Lundager Klokker Rausgaard
Inge Olga Ibsen
Palle Bach Nielsen Fruekilde
Ellen Aagaard Nohr
Per Damkier
Pernille Ravn
Screening of substance use in pregnancy: A Danish cross‐sectional study
Acta Obstetricia et Gynecologica Scandinavica
alcohol
cannabis
high risk pregnancy
maternal–fetal medicine
maternity care
neonatology
title Screening of substance use in pregnancy: A Danish cross‐sectional study
title_full Screening of substance use in pregnancy: A Danish cross‐sectional study
title_fullStr Screening of substance use in pregnancy: A Danish cross‐sectional study
title_full_unstemmed Screening of substance use in pregnancy: A Danish cross‐sectional study
title_short Screening of substance use in pregnancy: A Danish cross‐sectional study
title_sort screening of substance use in pregnancy a danish cross sectional study
topic alcohol
cannabis
high risk pregnancy
maternal–fetal medicine
maternity care
neonatology
url https://doi.org/10.1111/aogs.14862
work_keys_str_mv AT netelundagerklokkerrausgaard screeningofsubstanceuseinpregnancyadanishcrosssectionalstudy
AT ingeolgaibsen screeningofsubstanceuseinpregnancyadanishcrosssectionalstudy
AT pallebachnielsenfruekilde screeningofsubstanceuseinpregnancyadanishcrosssectionalstudy
AT ellenaagaardnohr screeningofsubstanceuseinpregnancyadanishcrosssectionalstudy
AT perdamkier screeningofsubstanceuseinpregnancyadanishcrosssectionalstudy
AT pernilleravn screeningofsubstanceuseinpregnancyadanishcrosssectionalstudy